Covid-19. Pneumonia due to SARS-associated coronavirus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age between 18-65 Written informed consent Covid-19 patients (PCR positive test or clinical symptoms such as fever > 38, respiratory rate = 24, dry cough, myalgia, asthenia, anosmia, and or anorexia Admission to general corvid-19 unit in hospital Patients who estimate that reside in hospital at least 7 days. Non ICU patients
Exclusion criteria
Exclusion criteria: Did not write informed consent Pregnancy and lactation Smoking Usage of other herbal medicine Hypertension (definition by ACC/AHA SBP/DBP = 130/80)
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Hospitalization days. Timepoint: Continuous. Method of measurement: Discharge day minus first day. | — |
Primary
| Measure | Time frame |
|---|---|
| C reactive protein. Timepoint: At baseline (day 0) and end of the study (day 8). Method of measurement: ELISA commercial diagnostic kit.;Assess the severity of cough. Timepoint: At baseline (day 0) and end of the study (day 8). Method of measurement: Visual Analogue Scale.;Alanine transaminase. Timepoint: At baseline (day 0) and end of the study (day 8). Method of measurement: Spectrophotometry.;Aspartate transaminase. Timepoint: At baseline (day 0) and end of the study (day 8). Method of measurement: Spectrophotometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Artesh University of Medical Sciences